Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Chitosan-based Hemostatic Gauze Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Chitosan-based Hemostatic Gauze Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Medical Devices & Consumables

Published Date: 2026-03-26

Pages: 77 Pages

Report ld: 6291754

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Chitosan-based Hemostatic Gauze market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.

Chitosan hemostatic gauze is a medical gauze made of natural polymer chitosan, which has excellent hemostatic properties and biocompatibility. Chitosan is a substance extracted from the shells of crustaceans that can promote platelet aggregation and blood clot formation, thereby accelerating the hemostasis process. This gauze is often used for wound treatment in trauma, surgery and emergency situations. It can not only stop bleeding quickly, but also reduce the risk of infection and promote wound healing.

In 2025, the North America Chitosan-based Hemostatic Gauze market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.

Major global manufacturers of Chitosan-based Hemostatic Gauze include Anscare, Tricol Biomedical, Advamedica, Hemoflex, Mermaid Medical, BioPharm Med, MedTrade Products, Shijiazhuang Yishengtang Medical Product, Biotemed, among others. In 2025, the top five players accounted for approximately % of global market revenue.

In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.

The global Chitosan-based Hemostatic Gauze market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.

MARKET SEGMENTATION

By Company

Anscare
Tricol Biomedical
Advamedica
Hemoflex
Mermaid Medical
BioPharm Med
MedTrade Products
Shijiazhuang Yishengtang Medical Product
Biotemed

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Z-shaped Folded Hemostatic Gauze
Non-folded Hemostatic Gauze

Segment by Application

Surgery
First Aid

biaoTi CHAPTER OUTLINE

Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term

Chapter 2: Quantitative analysis of Chitosan-based Hemostatic Gauze sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region

Chapter 3: Competitive landscape of Chitosan-based Hemostatic Gauze manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)

Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments

Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets

Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)

Chapter 7: Key manufacturer profiles –company overview, Chitosan-based Hemostatic Gauze product descriptions and specifications, revenue, gross margins, and recent developments

Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors

Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces

Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies

Chapter 11: Key findings, main takeaways, and overall conclusions of the report.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Chitosan-based Hemostatic Gauze value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Chitosan-based Hemostatic Gauze Product Scope

1.2 Chitosan-based Hemostatic Gauze by Type

1.2.1 Global Chitosan-based Hemostatic Gauze Sales by Type (2021, 2025 & 2032)

1.2.2 Z-shaped Folded Hemostatic Gauze

1.2.3 Non-folded Hemostatic Gauze

1.3 Chitosan-based Hemostatic Gauze by Application

1.3.1 Global Chitosan-based Hemostatic Gauze Sales Comparison by Application (2021, 2025 & 2032)

1.3.2 Surgery

1.3.3 First Aid

1.4 Global Chitosan-based Hemostatic Gauze Market Estimates and Forecasts (2021-2032)

1.4.1 Global Chitosan-based Hemostatic Gauze Market Size (Value) and Growth Rate (2021-2032)

1.4.2 Global Chitosan-based Hemostatic Gauze Market Size (Volume) and Growth Rate (2021-2032)

1.4.3 Global Chitosan-based Hemostatic Gauze Price Trends (2021-2032)

1.5 Assumptions and Limitations

2 Market Size and Prospects by Region

2.1 Global Chitosan-based Hemostatic Gauze Market Size by Region: 2021 VS 2025 VS 2032

2.2 Global Chitosan-based Hemostatic Gauze Historical Market Scenario by Region (2021-2026)

2.2.1 Global Chitosan-based Hemostatic Gauze Sales Market Share by Region (2021-2026)

2.2.2 Global Chitosan-based Hemostatic Gauze Revenue Market Share by Region (2021-2026)

2.3 Global Chitosan-based Hemostatic Gauze Market Estimates and Forecasts by Region (2027-2032)

2.3.1 Global Chitosan-based Hemostatic Gauze Sales Estimates and Forecasts by Region (2027-2032)

2.3.2 Global Chitosan-based Hemostatic Gauze Revenue Forecast by Region (2027-2032)

2.4 Major Regions and Emerging Market Analysis

2.4.1 North America Chitosan-based Hemostatic Gauze Market Size and Prospects (2021-2032)

2.4.2 Europe Chitosan-based Hemostatic Gauze Market Size and Prospects (2021-2032)

2.4.3 China Chitosan-based Hemostatic Gauze Market Size and Prospects (2021-2032)

2.4.4 Japan Chitosan-based Hemostatic Gauze Market Size and Prospects (2021-2032)

3 Global Market Size by Type

3.1 Global Chitosan-based Hemostatic Gauze Historical Market Review by Type (2021-2026)

3.1.1 Global Chitosan-based Hemostatic Gauze Sales by Type (2021-2026)

3.1.2 Global Chitosan-based Hemostatic Gauze Revenue by Type (2021-2026)

3.1.3 Global Chitosan-based Hemostatic Gauze Average Price by Type (2021-2026)

3.2 Global Chitosan-based Hemostatic Gauze Market Estimates and Forecasts by Type (2027-2032)

3.2.1 Global Chitosan-based Hemostatic Gauze Sales Forecast by Type (2027-2032)

3.2.2 Global Chitosan-based Hemostatic Gauze Revenue Forecast by Type (2027-2032)

3.2.3 Global Chitosan-based Hemostatic Gauze Price Forecast by Type (2027-2032)

3.3 Representative Players for Different Types of Chitosan-based Hemostatic Gauze

4 Global Market Size by Application

4.1 Global Chitosan-based Hemostatic Gauze Historical Market Review by Application (2021-2026)

4.1.1 Global Chitosan-based Hemostatic Gauze Sales by Application (2021-2026)

4.1.2 Global Chitosan-based Hemostatic Gauze Revenue by Application (2021-2026)

4.1.3 Global Chitosan-based Hemostatic Gauze Average Price by Application (2021-2026)

4.2 Global Chitosan-based Hemostatic Gauze Market Estimates and Forecasts by Application (2027-2032)

4.2.1 Global Chitosan-based Hemostatic Gauze Sales Forecast by Application (2027-2032)

4.2.2 Global Chitosan-based Hemostatic Gauze Revenue Forecast by Application (2027-2032)

4.2.3 Global Chitosan-based Hemostatic Gauze Price Forecast by Application (2027-2032)

4.3 New Sources of Growth in Chitosan-based Hemostatic Gauze Applications

5 Competition Landscape by Players

5.1 Global Chitosan-based Hemostatic Gauze Sales by Player (2021-2026)

5.2 Global Top Chitosan-based Hemostatic Gauze Players by Revenue (2021-2026)

5.3 Global Chitosan-based Hemostatic Gauze Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Chitosan-based Hemostatic Gauze revenue as of 2025

5.4 Global Chitosan-based Hemostatic Gauze Average Price by Company (2021-2026)

5.5 Global Key Manufacturers of Chitosan-based Hemostatic Gauze, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Chitosan-based Hemostatic Gauze, Product Type & Application

5.7 Global Key Manufacturers of Chitosan-based Hemostatic Gauze, Date of Entry into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Regional Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Chitosan-based Hemostatic Gauze Sales by Company

6.1.1.1 North America Chitosan-based Hemostatic Gauze Sales by Company (2021-2026)

6.1.1.2 North America Chitosan-based Hemostatic Gauze Revenue by Company (2021-2026)

6.1.2 North America Chitosan-based Hemostatic Gauze Sales Breakdown by Type (2021-2026)

6.1.3 North America Chitosan-based Hemostatic Gauze Sales Breakdown by Application (2021-2026)

6.1.4 North America Chitosan-based Hemostatic Gauze Major Customers

6.1.5 North America Market Trends and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Chitosan-based Hemostatic Gauze Sales by Company

6.2.1.1 Europe Chitosan-based Hemostatic Gauze Sales by Company (2021-2026)

6.2.1.2 Europe Chitosan-based Hemostatic Gauze Revenue by Company (2021-2026)

6.2.2 Europe Chitosan-based Hemostatic Gauze Sales Breakdown by Type (2021-2026)

6.2.3 Europe Chitosan-based Hemostatic Gauze Sales Breakdown by Application (2021-2026)

6.2.4 Europe Chitosan-based Hemostatic Gauze Major Customers

6.2.5 Europe Market Trends and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Chitosan-based Hemostatic Gauze Sales by Company

6.3.1.1 China Chitosan-based Hemostatic Gauze Sales by Company (2021-2026)

6.3.1.2 China Chitosan-based Hemostatic Gauze Revenue by Company (2021-2026)

6.3.2 China Chitosan-based Hemostatic Gauze Sales Breakdown by Type (2021-2026)

6.3.3 China Chitosan-based Hemostatic Gauze Sales Breakdown by Application (2021-2026)

6.3.4 China Chitosan-based Hemostatic Gauze Major Customers

6.3.5 China Market Trends and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Chitosan-based Hemostatic Gauze Sales by Company

6.4.1.1 Japan Chitosan-based Hemostatic Gauze Sales by Company (2021-2026)

6.4.1.2 Japan Chitosan-based Hemostatic Gauze Revenue by Company (2021-2026)

6.4.2 Japan Chitosan-based Hemostatic Gauze Sales Breakdown by Type (2021-2026)

6.4.3 Japan Chitosan-based Hemostatic Gauze Sales Breakdown by Application (2021-2026)

6.4.4 Japan Chitosan-based Hemostatic Gauze Major Customers

6.4.5 Japan Market Trends and Opportunities

7 Company Profiles and Key Figures

7.1 Anscare

7.1.1 Anscare Company Information

7.1.2 Anscare Business Overview

7.1.3 Anscare Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)

7.1.4 Anscare Chitosan-based Hemostatic Gauze Products Offered

7.1.5 Anscare Recent Development

7.2 Tricol Biomedical

7.2.1 Tricol Biomedical Company Information

7.2.2 Tricol Biomedical Business Overview

7.2.3 Tricol Biomedical Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)

7.2.4 Tricol Biomedical Chitosan-based Hemostatic Gauze Products Offered

7.2.5 Tricol Biomedical Recent Development

7.3 Advamedica

7.3.1 Advamedica Company Information

7.3.2 Advamedica Business Overview

7.3.3 Advamedica Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)

7.3.4 Advamedica Chitosan-based Hemostatic Gauze Products Offered

7.3.5 Advamedica Recent Development

7.4 Hemoflex

7.4.1 Hemoflex Company Information

7.4.2 Hemoflex Business Overview

7.4.3 Hemoflex Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)

7.4.4 Hemoflex Chitosan-based Hemostatic Gauze Products Offered

7.4.5 Hemoflex Recent Development

7.5 Mermaid Medical

7.5.1 Mermaid Medical Company Information

7.5.2 Mermaid Medical Business Overview

7.5.3 Mermaid Medical Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)

7.5.4 Mermaid Medical Chitosan-based Hemostatic Gauze Products Offered

7.5.5 Mermaid Medical Recent Development

7.6 BioPharm Med

7.6.1 BioPharm Med Company Information

7.6.2 BioPharm Med Business Overview

7.6.3 BioPharm Med Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)

7.6.4 BioPharm Med Chitosan-based Hemostatic Gauze Products Offered

7.6.5 BioPharm Med Recent Development

7.7 MedTrade Products

7.7.1 MedTrade Products Company Information

7.7.2 MedTrade Products Business Overview

7.7.3 MedTrade Products Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)

7.7.4 MedTrade Products Chitosan-based Hemostatic Gauze Products Offered

7.7.5 MedTrade Products Recent Development

7.8 Shijiazhuang Yishengtang Medical Product

7.8.1 Shijiazhuang Yishengtang Medical Product Company Information

7.8.2 Shijiazhuang Yishengtang Medical Product Business Overview

7.8.3 Shijiazhuang Yishengtang Medical Product Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)

7.8.4 Shijiazhuang Yishengtang Medical Product Chitosan-based Hemostatic Gauze Products Offered

7.8.5 Shijiazhuang Yishengtang Medical Product Recent Development

7.9 Biotemed

7.9.1 Biotemed Company Information

7.9.2 Biotemed Business Overview

7.9.3 Biotemed Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)

7.9.4 Biotemed Chitosan-based Hemostatic Gauze Products Offered

7.9.5 Biotemed Recent Development

8 Chitosan-based Hemostatic Gauze Manufacturing Cost Analysis

8.1 Chitosan-based Hemostatic Gauze Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Chitosan-based Hemostatic Gauze

8.4 Chitosan-based Hemostatic Gauze Industrial Chain Analysis

9 Marketing Channels, Distributors and Customers

9.1 Marketing Channels

9.2 Chitosan-based Hemostatic Gauze Distributors List

9.3 Chitosan-based Hemostatic Gauze Customers

10 Chitosan-based Hemostatic Gauze Market Dynamics

10.1 Chitosan-based Hemostatic Gauze Industry Trends

10.2 Chitosan-based Hemostatic Gauze Market Drivers

10.3 Chitosan-based Hemostatic Gauze Market Challenges

10.4 Chitosan-based Hemostatic Gauze Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Chitosan-based Hemostatic Gauze Sales (US$ Million) Growth Rate by Type (2021, 2025 & 2032)

Table 2. Global Chitosan-based Hemostatic Gauze Sales (US$ Million) Comparison by Application (2021, 2025 & 2032)

Table 3. Global Market Chitosan-based Hemostatic Gauze Market Size (US$ Million) by Region:2021 VS 2025 VS 2032

Table 4. Global Chitosan-based Hemostatic Gauze Sales (Units) by Region (2021-2026)

Table 5. Global Chitosan-based Hemostatic Gauze Sales Market Share by Region (2021-2026)

Table 6. Global Chitosan-based Hemostatic Gauze Revenue (US$ Million) Market Share by Region (2021-2026)

Table 7. Global Chitosan-based Hemostatic Gauze Revenue Share by Region (2021-2026)

Table 8. Global Chitosan-based Hemostatic Gauze Sales (Units) Forecast by Region (2027-2032)

Table 9. Global Chitosan-based Hemostatic Gauze Sales Market Share Forecast by Region (2027-2032)

Table 10. Global Chitosan-based Hemostatic Gauze Revenue (US$ Million) Forecast by Region (2027-2032)

Table 11. Global Chitosan-based Hemostatic Gauze Revenue Share Forecast by Region (2027-2032)

Table 12. Global Chitosan-based Hemostatic Gauze Sales by Type (Units) & (2021-2026)

Table 13. Global Chitosan-based Hemostatic Gauze Sales Share by Type (2021-2026)

Table 14. Global Chitosan-based Hemostatic Gauze Revenue by Type (US$ Million) & (2021-2026)

Table 15. Global Chitosan-based Hemostatic Gauze Average Price by Type (US$/Unit) & (2021-2026)

Table 16. Global Chitosan-based Hemostatic Gauze Sales by Type (Units) & (2027-2032)

Table 17. Global Chitosan-based Hemostatic Gauze Revenue by Type (US$ Million) & (2027-2032)

Table 18. Global Chitosan-based Hemostatic Gauze Average Price by Type (US$/Unit) & (2027-2032)

Table 19. Representative Players of Each Type

Table 20. Global Chitosan-based Hemostatic Gauze Sales by Application (Units) & (2021-2026)

Table 21. Global Chitosan-based Hemostatic Gauze Sales Share by Application (2021-2026)

Table 22. Global Chitosan-based Hemostatic Gauze Revenue by Application (US$ Million) & (2021-2026)

Table 23. Global Chitosan-based Hemostatic Gauze Average Price by Application (US$/Unit) & (2021-2026)

Table 24. Global Chitosan-based Hemostatic Gauze Sales by Application (Units) & (2027-2032)

Table 25. Global Chitosan-based Hemostatic Gauze Revenue Market Share by Application (US$ Million) & (2027-2032)

Table 26. Global Chitosan-based Hemostatic Gauze Average Price by Application (US$/Unit) & (2027-2032)

Table 27. New Sources of Growth in Chitosan-based Hemostatic Gauze Applications

Table 28. Global Chitosan-based Hemostatic Gauze Sales by Company (Units) & (2021-2026)

Table 29. Global Chitosan-based Hemostatic Gauze Sales Share by Company (2021-2026)

Table 30. Global Chitosan-based Hemostatic Gauze Revenue by Company (US$ Million) & (2021-2026)

Table 31. Global Chitosan-based Hemostatic Gauze Revenue Share by Company (2021-2026)

Table 32. Global Chitosan-based Hemostatic Gauze by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chitosan-based Hemostatic Gauze as of 2025)

Table 33. Global Market Chitosan-based Hemostatic Gauze Average Price by Company (US$/Unit) & (2021-2026)

Table 34. Global Key Manufacturers of Chitosan-based Hemostatic Gauze, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Chitosan-based Hemostatic Gauze, Product Type & Application

Table 36. Global Key Manufacturers of Chitosan-based Hemostatic Gauze, Date of Entry into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Chitosan-based Hemostatic Gauze Sales by Company (2021-2026) & (Units)

Table 39. North America Chitosan-based Hemostatic Gauze Sales Market Share by Company (2021-2026)

Table 40. North America Chitosan-based Hemostatic Gauze Revenue by Company (2021-2026) & (US$ Million)

Table 41. North America Chitosan-based Hemostatic Gauze Revenue Market Share by Company (2021-2026)

Table 42. North America Chitosan-based Hemostatic Gauze Sales by Type (2021-2026) & (Units)

Table 43. North America Chitosan-based Hemostatic Gauze Sales Market Share by Type (2021-2026)

Table 44. North America Chitosan-based Hemostatic Gauze Sales by Application (2021-2026) & (Units)

Table 45. North America Chitosan-based Hemostatic Gauze Sales Market Share by Application (2021-2026)

Table 46. Europe Chitosan-based Hemostatic Gauze Sales by Company (2021-2026) & (Units)

Table 47. Europe Chitosan-based Hemostatic Gauze Sales Market Share by Company (2021-2026)

Table 48. Europe Chitosan-based Hemostatic Gauze Revenue by Company (2021-2026) & (US$ Million)

Table 49. Europe Chitosan-based Hemostatic Gauze Revenue Market Share by Company (2021-2026)

Table 50. Europe Chitosan-based Hemostatic Gauze Sales by Type (2021-2026) & (Units)

Table 51. Europe Chitosan-based Hemostatic Gauze Sales Market Share by Type (2021-2026)

Table 52. Europe Chitosan-based Hemostatic Gauze Sales by Application (2021-2026) & (Units)

Table 53. Europe Chitosan-based Hemostatic Gauze Sales Market Share by Application (2021-2026)

Table 54. China Chitosan-based Hemostatic Gauze Sales by Company (2021-2026) & (Units)

Table 55. China Chitosan-based Hemostatic Gauze Sales Market Share by Company (2021-2026)

Table 56. China Chitosan-based Hemostatic Gauze Revenue by Company (2021-2026) & (US$ Million)

Table 57. China Chitosan-based Hemostatic Gauze Revenue Market Share by Company (2021-2026)

Table 58. China Chitosan-based Hemostatic Gauze Sales by Type (2021-2026) & (Units)

Table 59. China Chitosan-based Hemostatic Gauze Sales Market Share by Type (2021-2026)

Table 60. China Chitosan-based Hemostatic Gauze Sales by Application (2021-2026) & (Units)

Table 61. China Chitosan-based Hemostatic Gauze Sales Market Share by Application (2021-2026)

Table 62. Japan Chitosan-based Hemostatic Gauze Sales by Company (2021-2026) & (Units)

Table 63. Japan Chitosan-based Hemostatic Gauze Sales Market Share by Company (2021-2026)

Table 64. Japan Chitosan-based Hemostatic Gauze Revenue by Company (2021-2026) & (US$ Million)

Table 65. Japan Chitosan-based Hemostatic Gauze Revenue Market Share by Company (2021-2026)

Table 66. Japan Chitosan-based Hemostatic Gauze Sales by Type (2021-2026) & (Units)

Table 67. Japan Chitosan-based Hemostatic Gauze Sales Market Share by Type (2021-2026)

Table 68. Japan Chitosan-based Hemostatic Gauze Sales by Application (2021-2026) & (Units)

Table 69. Japan Chitosan-based Hemostatic Gauze Sales Market Share by Application (2021-2026)

Table 70. Anscare Company Information

Table 71. Anscare Description and Business Overview

Table 72. Anscare Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 73. Anscare Chitosan-based Hemostatic Gauze Product

Table 74. Anscare Recent Development

Table 75. Tricol Biomedical Company Information

Table 76. Tricol Biomedical Description and Business Overview

Table 77. Tricol Biomedical Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 78. Tricol Biomedical Chitosan-based Hemostatic Gauze Product

Table 79. Tricol Biomedical Recent Development

Table 80. Advamedica Company Information

Table 81. Advamedica Description and Business Overview

Table 82. Advamedica Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 83. Advamedica Chitosan-based Hemostatic Gauze Product

Table 84. Advamedica Recent Development

Table 85. Hemoflex Company Information

Table 86. Hemoflex Description and Business Overview

Table 87. Hemoflex Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 88. Hemoflex Chitosan-based Hemostatic Gauze Product

Table 89. Hemoflex Recent Development

Table 90. Mermaid Medical Company Information

Table 91. Mermaid Medical Description and Business Overview

Table 92. Mermaid Medical Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 93. Mermaid Medical Chitosan-based Hemostatic Gauze Product

Table 94. Mermaid Medical Recent Development

Table 95. BioPharm Med Company Information

Table 96. BioPharm Med Description and Business Overview

Table 97. BioPharm Med Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 98. BioPharm Med Chitosan-based Hemostatic Gauze Product

Table 99. BioPharm Med Recent Development

Table 100. MedTrade Products Company Information

Table 101. MedTrade Products Description and Business Overview

Table 102. MedTrade Products Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 103. MedTrade Products Chitosan-based Hemostatic Gauze Product

Table 104. MedTrade Products Recent Development

Table 105. Shijiazhuang Yishengtang Medical Product Company Information

Table 106. Shijiazhuang Yishengtang Medical Product Description and Business Overview

Table 107. Shijiazhuang Yishengtang Medical Product Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 108. Shijiazhuang Yishengtang Medical Product Chitosan-based Hemostatic Gauze Product

Table 109. Shijiazhuang Yishengtang Medical Product Recent Development

Table 110. Biotemed Company Information

Table 111. Biotemed Description and Business Overview

Table 112. Biotemed Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)

Table 113. Biotemed Chitosan-based Hemostatic Gauze Product

Table 114. Biotemed Recent Development

Table 115. Production Base and Market Concentration Rate of Raw Material

Table 116. Key Suppliers of Raw Materials

Table 117. Chitosan-based Hemostatic Gauze Distributors List

Table 118. Chitosan-based Hemostatic Gauze Customers List

Table 119. Chitosan-based Hemostatic Gauze Market Trends

Table 120. Chitosan-based Hemostatic Gauze Market Drivers

Table 121. Chitosan-based Hemostatic Gauze Market Challenges

Table 122. Chitosan-based Hemostatic Gauze Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Chitosan-based Hemostatic Gauze Product Picture

Figure 2. Global Chitosan-based Hemostatic Gauze Sales (US$ Million) by Type (2021, 2025 & 2032)

Figure 3. Global Chitosan-based Hemostatic Gauze Sales Market Share by Type in 2025 & 2032

Figure 4. Z-shaped Folded Hemostatic Gauze Product Picture

Figure 5. Non-folded Hemostatic Gauze Product Picture

Figure 6. Global Chitosan-based Hemostatic Gauze Sales (US$ Million) by Application (2021, 2025 & 2032)

Figure 7. Global Chitosan-based Hemostatic Gauze Sales Market Share by Application in 2025 & 2032

Figure 8. Surgery Examples

Figure 9. First Aid Examples

Figure 10. Global Chitosan-based Hemostatic Gauze Sales, (US$ Million), 2021 VS 2025 VS 2032

Figure 11. Global Chitosan-based Hemostatic Gauze Sales Growth Rate (2021-2032) & (US$ Million)

Figure 12. Global Chitosan-based Hemostatic Gauze Sales (Units) Growth Rate (2021-2032)

Figure 13. Global Chitosan-based Hemostatic Gauze Price Trends Growth Rate (2021-2032) & (US$/Unit)

Figure 14. Chitosan-based Hemostatic Gauze Report Years Considered

Figure 15. Global Market Chitosan-based Hemostatic Gauze Market Size (US$ Million) by Region:2021 VS 2025 VS 2032

Figure 16. Global Chitosan-based Hemostatic Gauze Revenue Market Share by Region: 2021 VS 2025

Figure 17. North America Chitosan-based Hemostatic Gauze Revenue (US$ Million) Growth Rate (2021-2032)

Figure 18. North America Chitosan-based Hemostatic Gauze Sales (Units) Growth Rate (2021-2032)

Figure 19. Europe Chitosan-based Hemostatic Gauze Revenue (US$ Million) Growth Rate (2021-2032)

Figure 20. Europe Chitosan-based Hemostatic Gauze Sales (Units) Growth Rate (2021-2032)

Figure 21. China Chitosan-based Hemostatic Gauze Revenue (US$ Million) Growth Rate (2021-2032)

Figure 22. China Chitosan-based Hemostatic Gauze Sales (Units) Growth Rate (2021-2032)

Figure 23. Japan Chitosan-based Hemostatic Gauze Revenue (US$ Million) Growth Rate (2021-2032)

Figure 24. Japan Chitosan-based Hemostatic Gauze Sales (Units) Growth Rate (2021-2032)

Figure 25. Global Chitosan-based Hemostatic Gauze Revenue Share by Type (2021-2026)

Figure 26. Global Chitosan-based Hemostatic Gauze Sales Share by Type (2027-2032)

Figure 27. Global Chitosan-based Hemostatic Gauze Revenue Share by Type (2027-2032)

Figure 28. Global Chitosan-based Hemostatic Gauze Revenue Share by Application (2021-2026)

Figure 29. Global Chitosan-based Hemostatic Gauze Revenue Market Share by Application in 2021 & 2025

Figure 30. Global Chitosan-based Hemostatic Gauze Sales Share by Application (2027-2032)

Figure 31. Global Chitosan-based Hemostatic Gauze Revenue Share by Application (2027-2032)

Figure 32. Global Chitosan-based Hemostatic Gauze Sales Share by Company (2025)

Figure 33. Global Chitosan-based Hemostatic Gauze Revenue Share by Company (2025)

Figure 34. Global 5 Largest Chitosan-based Hemostatic Gauze Players Market Share by Revenue in Chitosan-based Hemostatic Gauze: 2021 & 2025

Figure 35. Chitosan-based Hemostatic Gauze Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025

Figure 36. Manufacturing Cost Structure of Chitosan-based Hemostatic Gauze

Figure 37. Manufacturing Process Analysis of Chitosan-based Hemostatic Gauze

Figure 38. Chitosan-based Hemostatic Gauze Industrial Chain

Figure 39. Channels of Distribution (Direct Vs Distribution)

Figure 40. Distributors Profiles

Figure 41. Bottom-up and Top-down Approaches for This Report

Figure 42. Data Triangulation

Figure 43. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Chitosan-based Hemostatic Gauze market? zhanKai

The top companies in the global Chitosan-based Hemostatic Gauze market are Anscare、Tricol Biomedical、Advamedica.

Related Reports

Global Chitosan-based Hemostatic Gauze Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Chitosan-based Hemostatic Gauze market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 147
USD 4900.00
(Single User License)
Chitosan-based Hemostatic Gauze- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Chitosan-based Hemostatic Gauze was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-08
Pages: 107
USD 3950.00
(Single User License)
Global Chitosan-based Hemostatic Gauze Market Research Report 2026
The global Chitosan-based Hemostatic Gauze market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-08
Pages: 115
USD 2900.00
(Single User License)
Global Chitosan-based Hemostatic Gauze Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Chitosan-based Hemostatic Gauze market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 133
USD 4900.00
(Single User License)
Global Chitosan-based Hemostatic Gauze Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Chitosan-based Hemostatic Gauze market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 76
USD 4250.00
(Single User License)
Chitosan-based Hemostatic Gauze - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Chitosan-based Hemostatic Gauze was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 92
USD 3950.00
(Single User License)
Global Chitosan-based Hemostatic Gauze Market Research Report 2025
The global market for Chitosan-based Hemostatic Gauze was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 84
USD 2900.00
(Single User License)
Global and United States Chitosan-based Hemostatic Gauze Market Report & Forecast 2024-2030
Chitosan hemostatic gauze is a medical gauze made of natural polymer chitosan, which has excellent hemostatic properties and biocompatibility. Chitosan is a substance extracted from the shells of crustaceans that can promote platelet aggregation and blood clot formation, thereby accelerating the hemostasis process. This gauze is often used for wound treatment in trauma, surgery and emergency situations. It can not only stop bleeding quickly, but also reduce the risk of infection and promote wound healing.
Published Date: 2024-10-17
Pages: 105
USD 4350.00
(Single User License)
Global Chitosan-based Hemostatic Gauze Market Research Report 2024
Chitosan hemostatic gauze is a medical gauze made of natural polymer chitosan, which has excellent hemostatic properties and biocompatibility. Chitosan is a substance extracted from the shells of crustaceans that can promote platelet aggregation and blood clot formation, thereby accelerating the hemostasis process. This gauze is often used for wound treatment in trauma, surgery and emergency situations. It can not only stop bleeding quickly, but also reduce the risk of infection and promote wound healing.
Published Date: 2024-10-17
Pages: 78
USD 2900.00
(Single User License)
Global Chitosan-based Hemostatic Gauze Market Insights, Forecast to 2030
Chitosan hemostatic gauze is a medical gauze made of natural polymer chitosan, which has excellent hemostatic properties and biocompatibility. Chitosan is a substance extracted from the shells of crustaceans that can promote platelet aggregation and blood clot formation, thereby accelerating the hemostasis process. This gauze is often used for wound treatment in trauma, surgery and emergency situations. It can not only stop bleeding quickly, but also reduce the risk of infection and promote wound healing.
Published Date: 2024-10-17
Pages: 127
USD 4900.00
(Single User License)

Global Chitosan-based Hemostatic Gauze Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Chitosan-based Hemostatic Gauze market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 147
USD 4900.00 (Single User License)
Chitosan-based Hemostatic Gauze- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Chitosan-based Hemostatic Gauze was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-08
Pages: 107
USD 3950.00 (Single User License)
Global Chitosan-based Hemostatic Gauze Market Research Report 2026
The global Chitosan-based Hemostatic Gauze market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-08
Pages: 115
USD 2900.00 (Single User License)
Global Chitosan-based Hemostatic Gauze Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Chitosan-based Hemostatic Gauze market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 133
USD 4900.00 (Single User License)
Global Chitosan-based Hemostatic Gauze Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Chitosan-based Hemostatic Gauze market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 76
USD 4250.00 (Single User License)
Chitosan-based Hemostatic Gauze - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Chitosan-based Hemostatic Gauze was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 92
USD 3950.00 (Single User License)
Global Chitosan-based Hemostatic Gauze Market Research Report 2025
The global market for Chitosan-based Hemostatic Gauze was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 84
USD 2900.00 (Single User License)
Global and United States Chitosan-based Hemostatic Gauze Market Report & Forecast 2024-2030
Chitosan hemostatic gauze is a medical gauze made of natural polymer chitosan, which has excellent hemostatic properties and biocompatibility. Chitosan is a substance extracted from the shells of crustaceans that can promote platelet aggregation and blood clot formation, thereby accelerating the hemostasis process. This gauze is often used for wound treatment in trauma, surgery and emergency situations. It can not only stop bleeding quickly, but also reduce the risk of infection and promote wound healing.
Published: 2024-10-17
Pages: 105
USD 4350.00 (Single User License)
Global Chitosan-based Hemostatic Gauze Market Research Report 2024
Chitosan hemostatic gauze is a medical gauze made of natural polymer chitosan, which has excellent hemostatic properties and biocompatibility. Chitosan is a substance extracted from the shells of crustaceans that can promote platelet aggregation and blood clot formation, thereby accelerating the hemostasis process. This gauze is often used for wound treatment in trauma, surgery and emergency situations. It can not only stop bleeding quickly, but also reduce the risk of infection and promote wound healing.
Published: 2024-10-17
Pages: 78
USD 2900.00 (Single User License)
Global Chitosan-based Hemostatic Gauze Market Insights, Forecast to 2030
Chitosan hemostatic gauze is a medical gauze made of natural polymer chitosan, which has excellent hemostatic properties and biocompatibility. Chitosan is a substance extracted from the shells of crustaceans that can promote platelet aggregation and blood clot formation, thereby accelerating the hemostasis process. This gauze is often used for wound treatment in trauma, surgery and emergency situations. It can not only stop bleeding quickly, but also reduce the risk of infection and promote wound healing.
Published: 2024-10-17
Pages: 127
USD 4900.00 (Single User License)